Basic information
Biomarker: tumor-reactive CD8+ TILs
Full name: tumor-reactive CD4+ tumor infiltrating lymphocytes
Clinical application: prognosis (unfavorable)
Histology type: endometrial carcinoma
Cohort characteristics
Country: Spain
Region: Bellvitge
Cohort age: 70.36±10.28
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 47 | treatment-naïve EC | 47 |
Sample information
Sample type : tissue
Clinical method: flow cytometry;fluorescence activated cell sorting
Expression pattern : upregulated
